content: SECURITIES AND EXCHANGE COMMISSION
                          
               Washington, D.C.  20549
                          
                          
                      FORM 8-K
                          
                   CURRENT REPORT
                          
       Pursuant to Section 13 or 15(d) of the
           Securities Exchange Act of 1934
                          
  Date of Report (Date of earliest event reported): June 28, 1996
                          
                          
                          
  IMMUNOMEDICS, INC.                  
  (Exact name of registrant as specified in its charter)
                          
                          
                          
  Delaware                        0-12104           61-1009366
  (State or Other Jurisdiction    (Commission       (IRS Employer
   of Incorporation)               File Number)      Identification No.)
  
  
  
  300 American Road, Morris Plains, New Jersey            07950
  (Address of principal executive offices)              (Zip Code)
  
  
  
  Registrant's telephone number, including area code: (201) 605-8200
  
  
  
  
  (Former name or former address, if changed since last report)
                          
  <PAGE>                        
  
  
  Item 5.  Other Events
  
         The information contained in Exhibit 99 is incorporated herein 
       by reference.
  
  Item 7.  Financial Statement and Exhibits
  
       (c) Exhibits
  
            Exhibit 99 - Press Release, dated June 28, 1996
  
  <PAGE>
  
                     SIGNATURES
  
  
       Pursuant to the requirements of the Securities Exchange Act of 
       1934, the Registrant has duly caused this report to be signed on 
       its behalf by the undersigned thereunto duly authorized.
                                                    
  
                                               IMMUNOMEDICS, INC.
  
  
  
                                       By: /s/ David M. Goldenberg
                                               David M. Goldenberg
                                               Chairman of the Board and
                                               Chief Executive Officer
  
  
  Date: June 28, 1996
metadata_documents: [{"type": "8-K", "sequence": "1", "secsgml_size_bytes": 2081}]
metadata_filer: {"company-data": {"conformed-name": "IMMUNOMEDICS INC", "cik": "0000722830", "assigned-sic": "2835", "irs-number": "611009366", "state-of-incorporation": "DE", "fiscal-year-end": "0630"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "000-12104", "film-number": "96589221"}, "business-address": {"street1": "300 AMERICAN ROAD", "city": "MORRIS PLAINS", "state": "NJ", "zip": "07950", "phone": "201-605-8200"}, "mail-address": {"street1": "300 AMERICAN ROAD", "city": "MORRIS PLAINS", "state": "NJ", "zip": "07950"}}
text: SECURITIES AND EXCHANGE COMMISSION
                          
               Washington, D.C.  20549
                          
                          
                      FORM 8-K
                          
                   CURRENT REPORT
                          
       Pursuant to Section 13 or 15(d) of the
           Securities Exchange Act of 1934
                          
  Date of Report (Date of earliest event reported): June 28, 1996
                          
                          
                          
  IMMUNOMEDICS, INC.                  
  (Exact name of registrant as specified in its charter)
                          
                          
                          
  Delaware                        0-12104           61-1009366
  (State or Other Jurisdiction    (Commission       (IRS Employer
   of Incorporation)               File Number)      Identification No.)
  
  300 American Road, Morris Plains, New Jersey            07950
  (Address of principal executive offices)              (Zip Code)
  
  Registrant's telephone number, including area code: (201) 605-8200
  
  (Former name or former address, if changed since last report)
  Item 5.  Other Events
  
         The information contained in Exhibit 99 is incorporated herein 
       by reference.
  
  Item 7.  Financial Statement and Exhibits
  
       (c) Exhibits
  
            Exhibit 99 - Press Release, dated June 28, 1996
  SIGNATURES
  
       Pursuant to the requirements of the Securities Exchange Act of 
       1934, the Registrant has duly caused this report to be signed on 
       its behalf by the undersigned thereunto duly authorized.
                                                    
  
                                               IMMUNOMEDICS, INC.
  
                                       By: /s/ David M. Goldenberg
                                               David M. Goldenberg
                                               Chairman of the Board and
                                               Chief Executive Officer
  
  Date: June 28, 1996